News Archives | Palin Communications

Using powerful storytelling to spotlight juvenile arthritis

Palin Communications was proud to partner with not-for-profit organisation Juvenile Arthritis Foundation Australia (JAFA) on its 2026 Juvenile Arthritis Week campaign, using the power of storytelling to bring national attention to one of Australia’s most common, yet least understood, childhood autoimmune diseases.

Palin Account Directors bring home creative inspiration from Cairns Crocodiles

Two of Palin’s Account Directors recently travelled to Far North Queensland for Cairns Crocodiles, joining some of the communications and marketing industry’s brightest minds for one of the region’s leading creative events.

Turning a rare disease PBS listing into a national story

PBS listings are among the most important milestones in a medicine’s lifecycle, but they are also some of the most complex to communicate. Success requires a deep understanding of compliance, stakeholder management and the ability to translate highly technical information into stories that resonate with media and the wider community.

Health PR luminaries flex creative muscle

Experienced, creative health PR professionals from Palin Communications have been named finalists in the prestigious Cairns Hatchlings competition, where they will compete against top emerging talent to deliver a strategic response to a live United Nations Foundation brief at the Cairns Crocodiles creativity festival.

Our partnership with GSK Australia continues to raise the bar in shingles awareness

In October, we unveiled a first-of-its-kind public installation at Circular Quay, titled ‘What’s Your Hidden Health Baggage?’.

Neffy’s TGA milestone demonstrating the power of strategic health communication

TGA milestones are one of the few opportunities our clients have to speak directly to consumers about their products, so it’s critical their communication strategies measure up. That’s why we consider registration and reimbursements milestones to be the ‘bread and butter’ of what we do at Palin Communications.

Around 90% of drugs entering clinical trials fail. What if we could dramatically reduce that risk before a molecule ever reaches a lab?

OmnigeniQ’s Deterministic Intelligence platform grew out of NASA-linked research that was looking into insulin production in non-gravity environments, and where understanding how proteins behave under physical constraints was mission-critical.

Category: News